Education and counseling in the methadone treatment setting improves knowledge of viral hepatitis.
The aim of this study was to evaluate the effectiveness of an educational method of providing viral hepatitis education for methadone maintenance patients. Four hundred forty participants were randomly assigned to either a control or a motivationally-enhanced viral hepatitis education and counseling intervention. Viral hepatitis A (HAV), B (HBV), and C (HCV) knowledge tests were administered at baseline, following each of two education sessions (post-education), and at a 3-month follow-up assessment. Results indicated a significant increase in knowledge of HAV, HBV, and HCV over time. No differences were found in knowledge between the intervention groups in knowledge acquisition regarding any of the hepatitis viruses suggesting that a motivational interviewing style may not augment hepatitis knowledge beyond standard counseling. A two-session viral hepatitis education intervention effectively promotes hepatitis knowledge and can be integrated in methadone treatment settings.
University of California San Francisco, 1001 Potrero Ave., San Francisco, CA 94110, USA. Electronic address: Sandra.Larios@ucsf.edu.
Sandra E
SE
Larios
University of California San Francisco, 1001 Potrero Ave., San Francisco, CA 94110, USA.
Carmen L
CL
Masson
University of California San Francisco, 1001 Potrero Ave., San Francisco, CA 94110, USA.
Michael S
MS
Shopshire
University of Virginia, Department of Psychiatry and Neurobehavioral Sciences, UVA Center for Addiction Research and Education, 2821N. Parham Rd., Suite 203, Richmond, VA 23294, USA.
Jennifer
J
Hettema
Beth Israel Medical Center, 1st Ave., New York, NY 10003, USA.
Ashly E
AE
Jordan
Beth Israel Medical Center, 1st Ave., New York, NY 10003, USA.
Courtney
C
McKnight
Beth Israel Medical Center, 1st Ave., New York, NY 10003, USA.
Christopher
C
Young
University of California San Francisco, 1001 Potrero Ave., San Francisco, CA 94110, USA.
Mandana
M
Khalili
Beth Israel Medical Center, 1st Ave., New York, NY 10003, USA.
Randy M
RM
Seewald
Beth Israel Medical Center, 1st Ave., New York, NY 10003, USA.
Albert
A
Min
University of California San Francisco, 1001 Potrero Ave., San Francisco, CA 94110, USA.
Nicholas
N
Hengl
University of California San Francisco, 1001 Potrero Ave., San Francisco, CA 94110, USA.
James L
JL
Sorensen
Beth Israel Medical Center, 1st Ave., New York, NY 10003, USA; Center for Drug Use and HIV Research, 726 Broadway, 10th Floor, New York, NY 10003, USA.
Don C
DC
Des Jarlais
Beth Israel Medical Center, 1st Ave., New York, NY 10003, USA; Center for Drug Use and HIV Research, 726 Broadway, 10th Floor, New York, NY 10003, USA.
David C
DC
Perlman
D000328:Adult; D003376:Counseling / Q000379:methods*; D005260:Female; D005500:Follow-Up Studies; D007722:Health Knowledge, Attitudes, Practice; D006506:Hepatitis A / Q000517:prevention & control; D006509:Hepatitis B / Q000517:prevention & control; D006526:Hepatitis C / Q000517:prevention & control; D006801:Humans; D008297:Male; D008691:Methadone / Q000008:administration & dosage; D008875:Middle Aged; D062405:Motivational Interviewing / Q000379:methods; D058850:Opiate Substitution Treatment / Q000379:methods; D010353:Patient Education as Topic / Q000379:methods*; D013997:Time Factors
D008691:Methadone
Education; Hepatitis; Knowledge; Methadone